Testing effectiveness (Phase 2)UnknownNCT04979663What this trial is testingGEMOX Combined With Donafenib and Tislelizumab in Biliary Tract CancerWho this might be right forBiliary Tract Carcinoma Fudan University 10
Not applicableLooking for participantsNCT05184400What this trial is testingIdentification of New Biomarkers for Patients With Cholangiocarcinoma and Gallbladder CancerWho this might be right forBiliary Tract CancerCholangiocarcinomaGallbladder Cancer Herlev and Gentofte Hospital 500
Testing effectiveness (Phase 2)Study completedNCT03830606What this trial is testingThe Efficacy and Safety of Nab-paclitaxel Plus S-1 in First-line Treatment of Advanced Biliary Tract AdenocarcinomaWho this might be right forBiliary Tract Cancer Aiping Zhou 54
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06993025What this trial is testingIvonescimab in Combination With Liposomal Irinotecan and 5-FU/LV in Potentially Resectable Biliary Tract MalignanciesWho this might be right forBiliary Tract Cancer Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00948935What this trial is testingStudy of Gemcitabine, Irinotecan and Panitumumab in Patients With Advanced and Metastatic Biliary Tract AdenocarcinomaWho this might be right forBiliary CancerCholangiocarcinoma Abramson Cancer Center at Penn Medicine 35
Testing effectiveness (Phase 2)Ended earlyNCT00085410What this trial is testingBortezomib in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or GallbladderWho this might be right forAdenocarcinoma of the Extrahepatic Bile DuctAdenocarcinoma of the GallbladderAdvanced Adult Primary Liver Cancer+7 more National Cancer Institute (NCI) 20
Not applicableNo Longer AvailableNCT04087876What this trial is testingExpanded Access Use of Derazantinib for Advanced Intrahepatic Cholangiocarcinoma (iCCA) With FGFR Genomic AlterationsWho this might be right forIntrahepatic Cholangiocarcinoma Basilea Pharmaceutica
Not applicableUnknownNCT05493878What this trial is testingITGA2b and SELP Expression in Cancer Pancreas and Biliary Tract CancerWho this might be right forPancreas Cancer Assiut University 128
Testing effectiveness (Phase 2)UnknownNCT04191343What this trial is testingClinical Study on the First-line Treatment of Advanced Biliary System Tumors With Tripley Monoclonal Antibody Combined With GEMOX RegimenWho this might be right forAdvanced Biliary Tract Tumors Zhejiang Cancer Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT07831993What this trial is testingSintilimab Plus NALIRIFOX or Gemcitabine-Cisplatin as First-Line Treatment for Metastatic Biliary Tract CancerWho this might be right forBiliary Tract Cancer The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 54
Large-scale testing (Phase 3)Looking for participantsNCT05786716What this trial is testingDETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating MutationsWho this might be right forHaematological MalignancyColorectal NeoplasmsUrinary Bladder Neoplasm+8 more Cancer Research UK 30
Testing effectiveness (Phase 2)UnknownNCT03772132What this trial is testingChemothetapy FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder CarcinomaWho this might be right forCholangiocarcinoma of the Extrahepatic Bile DuctGallbladder Cancer Shanghai Jiao Tong University School of Medicine 100
Not applicableUnknownNCT04584996What this trial is testingCIRcular and Non-coding RNAs as Clinically USeful Biomarkers in Pancreaticobiliary CancersWho this might be right forPancreatic CancerBiliary Tract Cancer Royal Surrey County Hospital NHS Foundation Trust 186
Early research (Phase 1)Ended earlyNCT02714374What this trial is testingGL-ONC1 Administered Intravenously Prior to Surgery to Patients With Solid Organ CancersWho this might be right forSolid Organ Cancers Andrew Lowy 5
Testing effectiveness (Phase 2)Looking for participantsNCT07450976What this trial is testingSHR-A1904 in Previous Systemic Treatment Failed Biliary Tract CancerWho this might be right forBiliary Tract Cancer Suzhou Suncadia Biopharmaceuticals Co., Ltd. 151
Testing effectiveness (Phase 2)UnknownNCT05911425What this trial is testingCombined Treatment of Treated Bile Duct CancerWho this might be right forBile Duct Cancer Zhejiang Cancer Hospital 30
Not applicableStudy completedNCT02626195What this trial is testingPreoperative Nutritional Support in Malnutritional Cancer PatientsWho this might be right forPancreatic CancerBiliary CancerMalnutrition National Cancer Center, Korea 50
Early research (Phase 1)Looking for participantsNCT06065371What this trial is testingSacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard TherapyWho this might be right forGastrointestinal Cancer Henry Ford Health System 20
Testing effectiveness (Phase 2)Study completedNCT01943864What this trial is testingA Phase IIa Study of the MEK Inhibitor Trametinib Monotherapy in the Treatment of Biliary Tract CancersWho this might be right forCancer GlaxoSmithKline 20
Testing effectiveness (Phase 2)UnknownNCT03898895What this trial is testingCOmbination of Radiotherapy With Anti-PD-1 Antibody for unREseCtable Biliary Tract CancerWho this might be right forBiliary Tract CancerRadiotherapyImmunotherapy Sun Yat-sen University 36